May 2026

FMR Resources has received final assays from drillhole 26LHDD073 at its Southern Porphyry target, confirming extensive copper-gold-molybdenum mineralisation and supporting the interpretation of a large porphyry system. Ongoing integration of geological and geophysical data aims to refine targets ahead of Phase II drilling.

Orange Minerals NL has agreed to sell its 51% interest in the Calarie Project tenements to Adavale Resources, receiving shares and options in return. This move supports Orange Minerals' focus on its core gold projects in Ghana and Western Australia.

Canadian Phosphate (ASX: CP8) is raising up to AUD 4.85 million via a renounceable rights issue at a 22% discount, aiming to accelerate development of its newly acquired Diamond Mountain Project in Utah and advance exploration in Canada.

Speculative small caps drove the week, with Tasman Resources, Solis Minerals and Lithium Energy leading the board after funding, drilling and asset sale updates. At the other end, ASX Ltd and Arafura Rare Earths fell hard as investors reacted to higher costs and fresh equity issuance.

ASX Ltd sank, while Klevo and Judo Bank surged as investors split sharply between costly regulatory problems and clearer growth plans. Payments, retirement income and capital management drove the busiest finance stories of the week.

Small-cap materials stocks swung hard as fresh funding, mine build decisions and standout drill hits drove the week’s biggest moves. Gold, lithium, rare earths and tungsten names all drew buying, while a few raisings and weak follow-through after trading halts kept losses sharp.

Biotech names led healthcare trading this week, with Noxopharm, Acrux and TruScreen posting the biggest moves after clinical, licensing and expansion updates. Stronger cash flow, fresh capital and new contracts also lifted sentiment across medtech, aged care and healthcare services.

Tiny tech stocks dominated the tape, with Thrive Tribe, Harvest Technology and Bridge SaaS posting the biggest weekly jumps. Capital raisings, AI product launches and defence-linked deals drove buying, while heavily discounted offers and fraud concerns hit the losers.

Venus Metals has sold its 1% Youanmi gold royalty to Franco-Nevada for $46 million, triggering plans for $35 million in special dividends and an in-specie distribution of Rox shares to shareholders.

Findi Limited surged revenue by 36% to $83 million for FY26 but posted a hefty $52.6 million net loss, weighed down by integration costs and capital delays. The company completed a major consolidation of its Indian financial infrastructure assets and secured $25 million in fresh capital to support growth and liquidity.

Evion Group has increased the size of its second tranche placement, lifting total capital raised to A$7.24 million through the issue of over 241 million shares at 3 cents each. The second tranche awaits shareholder approval at a July meeting, including director participation and free attaching options.

IDP Education (ASX:IEL) has responded to an ASX price query following a sharp share price fall and increased trading volume, attributing the movement to a late analyst downgrade and confirming compliance with continuous disclosure rules.

Sequoia Financial Group has pushed back its interim dividend payment to 29 June 2026 due to unresolved court proceedings and negotiations over the sale of its InterPrac subsidiary. The Federal Court has set a tight timetable for filings on the Share Sale Agreement status, with a potential hearing in July.

Third Age Health Services posted a 17.9% revenue increase and 24.7% profit rise for FY26, driven by strategic acquisitions and expansion in aged residential care services.

Superloop has finalized its $165 million purchase of Lightning Broadband, adding 56,000 secured lots to its Fibre-to-the-Premises network across six Australian states and territories. The deal, funded by cash and debt, keeps net leverage low and comes with regulatory approval of a functional separation framework to support open-access wholesale services.

ANZ Bank New Zealand has lodged an appeal against a High Court summary judgment in a class action related to consumer credit laws, prolonging legal uncertainty for the lender.

Bass Oil Limited offers up to 24 million free attaching options to recent placement participants, alongside nearly 8 million options to its lead manager PAC Partners, with no new funds raised from the options issue.

Sarama Resources has secured A$1.42 million through the first tranche of its A$1.5 million equity placement, with the second tranche involving director participation pending shareholder approval.

Amplia Therapeutics reported encouraging mature data from its ACCENT pancreatic cancer trial showing improved survival and response rates with narmafotinib. The company raised $27.5 million to fund development and manufacturing scale-up, while discontinuing a parallel trial due to chemotherapy toxicity.

Excite Technology Services lifted revenue by 74% to $21.3 million in FY26 but still recorded a $5.4 million loss, with auditors flagging material uncertainty over its ability to continue as a going concern.

Burger Fuel Group reported a 91.8% surge in net profit to NZD 1.97 million for FY26, driven by sales growth, reduced legal costs, and a one-off store sale gain, despite geopolitical headwinds in the Middle East.

Papyrus Australia has secured a key milestone under its TBS Mining Contract by executing a board production deal with a Vietnam manufacturer, while raising $325,000 to support commercial scale-up and facility establishment.

Acrux has locked in a milestone-based licensing agreement worth up to AUD 5.4 million for Lenzetto®, targeting the Australian menopause therapy market with regulatory and commercial milestones tied to TGA approval and sales performance.

Green Technology Metals (ASX: GT1) secured $1.87 million from its recent entitlement offer, with underwriters stepping in to cover a $2.13 million shortfall. The capital raise supports ongoing development of its Ontario lithium project.